Hearing lots of hype about MicroBot. Looks pretty solid. Regulatory: 510(k) submission complete; FDA decision expected Q3 2025 Clinical Evidence: ACCESS-PVI trial: 100% success, 0 adverse events, 92% radiation reduction Funding & Resources: Non-dilutive grant + $8.6M capital raise Commercial Readiness: Executive hires; Russell Index inclusion Global Expansion: Patent granted in China; strong IP strategy Earnings coming up… What do yall think?
No replies yet. Be the first to reply!
Choose a platform: